-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Reiterates Equal-Weight on Insight Molecular, Maintains $4 Price Target

Benzinga·11/18/2026 13:59:35
Listen to the news
Stephens & Co. analyst Mason Carrico reiterates Insight Molecular (NASDAQ:IMDX) with a Equal-Weight and maintains $4 price target.